UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042424
Receipt number R000048431
Scientific Title Prevalence of Right Ventricular Dysfunction-Pulmonary Hypertension and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis
Date of disclosure of the study information 2020/11/11
Last modified on 2021/07/17 10:16:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prevalence of Right Ventricular Dysfunction-Pulmonary Hypertension and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis

Acronym

Prevalence of Right Ventricular Dysfunction-Pulmonary Hypertension and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis

Scientific Title

Prevalence of Right Ventricular Dysfunction-Pulmonary Hypertension and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis

Scientific Title:Acronym

Prevalence of Right Ventricular Dysfunction-Pulmonary Hypertension and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis

Region

Asia(except Japan)


Condition

Condition

COVID-19

Classification by specialty

Medicine in general Cardiology Pneumology
Infectious disease Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the prevalence of right ventricular dysfunction-pulmonary hypertension AND its association with COVID-19 clinical outcome.

Basic objectives2

Others

Basic objectives -Others

To analyze the prevalence and association of pulmonary hypertension with COVID-19 outcome

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Composite poor outcome of severity. mortality, need for ICU and mechanical ventilation

Key secondary outcomes

each percentage of primary outcome: severity. mortality, need for ICU and mechanical ventilation


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

all observational studies or trials that involving adult patients with COVID-19 that had any data of right ventricular dysfunction and pulmonary arterial hypertension for comparison poor vs good outcome

Key exclusion criteria

missing required data, no data on RVD/ PAH, no outcome of interest, other than english language

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Eka
Middle name Prasetya Budi
Last name Mulia

Organization

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Division name

Department of Cardiology and Vascular Medicine

Zip code

60131

Address

Jl. Mayjen Prof. Dr. Moestopo 47

TEL

62-8562765365

Email

eka.prasetya.budi-2017@fk.unair.ac.id


Public contact

Name of contact person

1st name Eka
Middle name Prasetya Budi
Last name Mulia

Organization

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Division name

Department of Cardiology and Vascular Medicine

Zip code

60131

Address

Jl. Mayjen Prof. Dr. Moestopo 47

TEL

628562765365

Homepage URL

https://www.researchgate.net/profile/Eka_Mulia

Email

eka.prasetya.budi-2017@fk.unair.ac.id


Sponsor or person

Institute

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Komite Etik Penelitian Kesehatan RSUD Dr Soetomo, Surabaya, Indonesia

Address

Jalan Mayjen. Prof. Dr. Moestopo No. 6-8, Surabaya, Jawa Timur 60286

Tel

0315501011

Email

kontak@rsudrsoetomo.jatimprov.go.id


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.5114/aoms/136342

Number of participants that the trial has enrolled

1728

Results

Pooled prevalence of RVD in COVID-19 was 19% and PH was 22%. RVD and PH was associated with increased mortality, severity , ICU admission, and mechanical ventilation.

Results date posted

2021 Year 01 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 11 Month 11 Day

Date of IRB

2020 Year 11 Month 03 Day

Anticipated trial start date

2020 Year 11 Month 11 Day

Last follow-up date

2020 Year 11 Month 11 Day

Date of closure to data entry

2020 Year 12 Month 15 Day

Date trial data considered complete

2020 Year 12 Month 25 Day

Date analysis concluded

2020 Year 12 Month 31 Day


Other

Other related information

A systematic search of all observational studies or trials that involving adult patients with COVID-19 that had any data of RVD and PAH for comparison of poor vs good outcome was carried out using the PubMed, Science Direct, Scopus, ProQuest, and MedRxiv databases.


Management information

Registered date

2020 Year 11 Month 11 Day

Last modified on

2021 Year 07 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048431


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name